Recently, deregulation of flotillin-1 was found in epithelium-originated cancer, including breast cancer [7], colorectal cancer [8], and esophageal squamous cell carcinoma [9, 10]. Here, FLOT1 is linked to esophageal squamous cell carcinoma.